Vermont Medicare Bridge for GLP-1 Weight Loss | Montpelier News

Starting Wednesday, Medicare patients in Vermont can access GLP-1 weight-loss drugs like Ozempic and Wegovy through a new Bridge Program—designed specifically for those seeking weight management, not treating diabetes or sleep apnea. With a $50 co-pay and approval from your doctor, this initiative fills a critical gap after insurers pulled coverage for weight loss. Medicaid expansion remains unlikely due to high costs, but this program offers a vital lifeline for eligible Vermonters. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a56c0c1cfba79689